← FDA Drug Approvals (Drugs@FDA)

FONDAPARINUX SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BRIGHTGENE · Approved 2024-12-18

Drug application

FDA Application #

ANDA218312

Application type

Abbreviated New Drug Application (Generic)

Brand name

FONDAPARINUX SODIUM

Generic name

Fondaparinux Sodium

Active ingredients

FONDAPARINUX SODIUM

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

BRIGHTGENE

First approval

2024-12-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown